Lundbeck
HLUN-B.CO
$4.68
Share price
-1.33%
Change (1 day)
-11.03%
Change (1 year)
Categories
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.
Market capitalization of Lundbeck (HLUN-B.CO)
Market cap: $4.51 Billion
As of April 2024 Lundbeck has a market cap of $4.51 Billion. This makes Lundbeck the world's 2769th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Lundbeck from 2005 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $4.51 B | -4.06% |
| 2023 | $4.70 B | 30.15% |
| 2022 | $3.61 B | 426.21% |
| 2021 | $0.68 B | -25.48% |
| 2020 | $0.92 B | -9.14% |
| 2019 | $1.01 B | -12.84% |
| 2018 | $1.16 B | -13.86% |
| 2017 | $1.35 B | 24.56% |
| 2016 | $1.08 B | 18.94% |
| 2015 | $0.91 B | 72.43% |
| 2014 | $0.52 B | -20.71% |
| 2013 | $0.66 B | 72.63% |
| 2012 | $0.38 B | -41.49% |
| 2011 | $0.66 B | 32.88% |
| 2010 | $0.49 B | 1.2% |
| 2009 | $0.49 B | -18.4% |
| 2008 | $0.60 B | -17.79% |
| 2007 | $0.73 B | -5.33% |
| 2006 | $0.77 B | 24.95% |
| 2005 | $0.61 B |
End of Day market cap according to different sources
On Apr 25th, 2024 the market cap of Lundbeck was reported to be:
$4.51 Billion
$4.51 Billion